Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
610 results
  1. NLM Digital Collections - 12/2/1983-12/30/1983 
    https://resource.nlm.nih.gov/101637321X12
    ... of Kaposi's Sarcoma/AIDS patients are comprised of chemotherapy regimens which | involve combinations of cytoxic drugs and radiotherapy procedures for Kaposi's ...
  2. NLM Digital Collections - Treatment of primary breast cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), September 2013
    resource.nlm.nih.gov/101671096
    ... of the relative benefits and risks of these regimens should be made when recommending a chemotherapy combination. Febrile neutropenia rates may be reduced with the ...
  3. NLM Digital Collections - Diagnosis and management of colorectal cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), August 2016
    resource.nlm.nih.gov/101609347
    ... failure of fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. Bevacizumab (Avastin) is not recommended for use within NHSScotland in combination with fluoropyrimidine- based chemotherapy for treatment of patients with metastatic carcinoma of ...
  4. NLM Digital Collections - Management of adult testicular germ cell tumours : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), March 2011
    resource.nlm.nih.gov/101609344
    ... intensive schedule.81,85 The use of alternating regimens has also been addressed in other studies. The rationale for alternating administration of different chemotherapy combinations is based on the theoretical consideration that a ...
  5. NLM Digital Collections - Management of epithelial ovarian cancer : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), 2013
    resource.nlm.nih.gov/101671098
    ... with relapsed ovarian cancer what is the optimal chemotherapy 6.3 regimen? Consider: platinum (carboplatin), taxanes (paclitaxel), topotecan, bevacizumab, gemcitabine, trabectedin, pegylated liposomal doxorubicin; consider mono and combination therapies (eg single agent carboplatin and combination of ...
  6. NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018
    resource.nlm.nih.gov/101744954
    ... months of first diagnosis Frame: 6 months] With chemotherapy and treatment with combination Secondary Outcome Measures Relapsed/Refractory Multicenter regimen of chemoimmunotherapy] OR Progression of iNHL • Progression Free ...
  7. NLM Digital Collections - Indication-specific pricing of pharmaceuticals in the United States health care system : a ... 
    Publication: Boston, MA : Institute for Clinical and Economic Review, March 2016
    resource.nlm.nih.gov/101704608
    ... by the EC in July 2014, was: in combination with paclitaxel, topotecan, or ... prior chemotherapy regimens and who have not received prior therapy with ...
  8. NLM Digital Collections - Briefing Book for Hearings, 1989 
    https://resource.nlm.nih.gov/101083016X32
    ... practitio- ners. This will be especially true if combination chemotherapy becomes the norm, requiring detailed therapeu- tie regimens that may cause toxic reac- tions. Despite these ...
  9. NLM Digital Collections - Paper submitted [briefing packet], Nov. 2-3, 1989 
    https://resource.nlm.nih.gov/101083016X33
    ... practitio- ners. This will be especially true if combination chemotherapy becomes the norm, requiring detailed therapeu- tic regimens that may cause toxic reac- tions. Despite these ...
  10. Changing the Face of Medicine | Jean R. Anderson 
    https://cfmedicine.nlm.nih.gov/physicians/biography_9.html
    ... support patients and help women manage their treatment regimen. This is ... therapies. Dr. Anderson has developed a national and international ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last